Combined biopsy method improves diagnostic accuracy in prostate cancerMarch 4, 2020Genitourinary CancerProstate CancerOncology
Gene therapy appears effective in bladder cancer patients with few optionsFebruary 26, 2020Genitourinary CancerOncology
Lenvatinib/pembrolizumab has good activity in advanced RCC, other solid tumorsJanuary 31, 2020Genitourinary CancerMelanomaLung CancerHead & Neck/Thyroid CancersOncology
Combo shows promise for checkpoint inhibitor-refractory urothelial carcinomaNovember 12, 2019Genitourinary CancerOncology
Sperm counts largely stable after adjuvant treatment of clinical stage I testicular cancerMarch 1, 2019Genitourinary CancerOncology
First-line avelumab/axitinib for RCC benefits wide range of patientsFebruary 21, 2019Genitourinary Cancer
Poor-prognosis cancers linked to highest suicide risk in first yearJanuary 7, 2019OncologyBreast CancerGenitourinary CancerLung CancerMelanomaHematology
Abiraterone also benefits low-risk metastatic prostate cancer patientsNovember 13, 2018Genitourinary Cancer
STAMPEDE: Radiation to prostate boosts survival of metastatic cancerOctober 22, 2018Genitourinary CancerOncology
Checkpoint inhibitor/TKI combo improves PFS of RCC over sunitinibOctober 22, 2018Genitourinary Cancer
